Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Preferred Stock Liabilities: 2020

  • Cellebrite DI's Preferred Stock Liabilities was N/A to $101.2 million in Q4 2020 from the same period last year, while for Dec 2020 it was $101.2 million, marking a year-over-year change of. This contributed to the annual value of $101.2 million for FY2020, which is N/A change from last year.
  • According to the latest figures from Q4 2020, Cellebrite DI's Preferred Stock Liabilities is $101.2 million.
  • Cellebrite DI's 5-year Preferred Stock Liabilities high stood at $101.2 million for Q4 2020, and its period low was $101.2 million during Q4 2020.
  • Over the past 1 years, Cellebrite DI's median Preferred Stock Liabilities value was $101.2 million (recorded in 2020), while the average stood at $101.2 million.